The disclosure comes after Celsius and other energy drink manufacturers face mounting scrutiny for allegedly failing to ...
Following a massive 162 percent surge in prescriptions and a major FDA label reversal, a critical shortage of estradiol ...
MedPage Today on MSN
FDA expands risankizumab label in psoriatic disease
IL-23 inhibitor lands indications for kids 6 years and up ...
GlobalData on MSN
FDA widens Vertex’s Casgevy use for paediatric patients
Children as young as two with either sickle cell disease or thalassemia are now eligible for the gene therapy.
Zacks Investment Research on MSN
FDA expands IONS' Tryngolza label to treat severe hypertriglyceridemia
Ionis Pharmaceuticals IONS announced that the FDA has approved its wholly owned drug, Tryngolza (olezarsen), for a new ...
Second, the changes would ease longstanding warnings about the use of the hormone therapy in those with prostate cancer.
The U.S. Food and Drug Administration (FDA) has announced the food supply issues it seeks to tackle by year's end.
The FDA announced it has approved two new drugs to expand treatment options for menopausal symptoms. (HHS) The Food and Drug Administration (FDA) will remove broad “black box” warning labels from ...
The US Food and Drug Administration (FDA) on Tuesday announced class-wide safety labeling changes for immediate-release (IR) opioid pain medications, which make up about 90% of all opioid ...
Pfizer (PFE) stock is in focus as the FDA approves a label expansion therapy for breast cancer therapy, palbociclib, marketed ...
Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results